Compare MasTec Inc (MTZ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs GeneDx Holdings Corp — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: MasTec Inc is far larger — about 14.8× GeneDx Holdings Corp's market cap, and MasTec Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| MTZ | WGS | |
|---|---|---|
Market Cap | $26.60B | $1.80B |
Sector | Technology | Technology |
52-Week High | $437.51 | $167.51 |
52-Week Low | $172.51 | $34.51 |
Enterprise Value | $29.34B | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
